Green peptide, linking the world | Congen pharma x CPHI China 2025 successfully concluded!
Publish Time:
2025-07-07
From June 24th to 26th, the 23rd World Pharmaceutical Raw Materials China Exhibition (CPHI China 2025) was successfully held at the Shanghai New International Expo Center. This global pharmaceutical raw materials event, bringing together over 3,500 exhibitors and attracting more than 100,000 professional visitors, provided a broad platform for industry communication and innovation. Tongjun Pharmaceutical showcased its green peptide synthesis platform and drug peptide industry chain products, attracting considerable attention.
Congen pharma is committed to making sustainable and affordable peptides accessible for human beauty and health. This time, it brought the world's first EMPHASES ® new liquid-phase peptide synthesis platform. This platform replaces traditional solid-phase resins with liquid-phase carriers, greatly improving reaction speed, shortening reaction time, and increasing synthesis efficiency. At the same time, it reduces the amount of amino acids, coupling reagents, and solvents used, reducing three wastes emissions and effectively controlling costs. It has currently obtained 5 Chinese invention patents, 1 US patent, and 1 Japanese patent authorization. Its value attracted widespread attention during the exhibition. Tongjun Pharmaceutical conducted in-depth discussions with pharmaceutical companies and research institutions at home and abroad on technology application and industrialization cooperation, further consolidating its global layout.
In addition, in the hot drug peptide fields such as semaglutide and tirzepatide, Tongjun Pharmaceutical exhibited a full industry chain of products covering side chains, intermediates, peptide fragments, and oral enhancers. With its quality and price advantages, it provides strong support for the industry and has won the favor of many customers.
The three-day exhibition was exciting and concluded successfully! In the future, Congen pharma will continue to focus on the research and development and production of peptides, work hand in hand with global partners, contribute to the innovative development of the pharmaceutical industry, and create a better and healthier future together!
